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The Polyoma virus enhancer (A + B domain) activates transcription m SaccharomJ~ces crreri.sruc when joined to appropriate yeast promoter 
elements. We demonstrate by DNase I footprmts and mhibttion of bindmg by specific antibody, that the yeast protein RAP1 binds to the B-domain 
of the Polyoma enhancer and. at least in some promoter contexts. is responsible for transcriptional acttvtty of the enhancer B-domain in yeast 
Close matches to a consensus RAPl-bindmg site are also present in other viral enhancers. 
Transcription factor: Polyoma enhancer; Succlzcrroni)ces cereoike: RAP1 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Viral transcriptional enhancers consist of multiple se- 
quences that match DNA binding activator proteins 
present in host tissues [1,2]. In a previous work [3,4] we 
replaced a native UAS element in a truncated yeast 
promoter with the Polyoma virus enhancer and ob- 
served activation of transcription of a reporter gene. 
This result suggests that the enhancer element contains 
evolutionarily conserved binding sites for one or more 
yeast proteins, which can drive RNA synthesis in con- 
cert with the basal transcriptional machinery in yeast. 
We have screened for such yeast proteins that bind 
to the Polyoma enhancer and identify a yeast protein 
that binds in vitro to a sequence within the B-domain, 
one of the two major domains of the Polyoma enhancer. 
We show that this protein is repressor/activator protein 
RAP1 (also known as TUFl/GRFl) [5] and that, in 
some promoter contexts. it is by itself responsible for 
enhancer activity in yeast. RAP1 is a scaffold-associated 
structural protein that plays a multifunctional role in 
the cell: activation and silencing of transcription as well 
as chromosome maintenance and stimulation of meiotic 
recombination [S-7]. Although such a protein has so far 
not been described in other organisms besides yeast, the 
presence of potential RAP1 binding sites in Polyoma 
and other viral enhancers is suggestive of the presence 
of a RAP1 protein homologue in mammals. 
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2 1. Srrurrzs and plusrmds 
In E ccl;. plasmids were usually transformed and maintained in the 
ret A stram HBlOl (F-, hsd, S20. rB mB, recA13. ara-14. proA2, 
lacy 1, galK2. rpsL20 Smr. xyl5. mtl-1, supE-44). selecting for ampi- 
cilhn reststance For preparing DNA to be cut with StuI endonuclease, 
plasmids were transformed mto E co/r strain 577 dcm-. 
In Succhurorn~ce.s cerrru~~r, plasmids were usually transformed 
and mamtained m yeast strain ScKYll7 (a, ura3352. trpl-dell, his3- 
de1200. ade22101, lys22801). 
Protein extract was prepared from the diplotd strain DE 417 (a 
etrpl-dell, his3-de1200, ade22101, lys2-801, trpl-289). 
To examine RAP1 dependence of transcription we constructed the 
following stram: (his3-del200. ade2-101. trpl, ura3-52. gncl”); gncl” 
is a temperature-sensitive mutation in gene RAP1 (a gift from M. 
Brettenbach). Standard genettc techniques were used to integrate the 
test plasmtds at the TRPl locus on chromosome IV. Copy number and 
site of mtegratton were determined by Southern blottmg of appropri- 
ate restrictton enzyme digests of yeast DNA. 
Test plasmids have been described previously [3] In particular. 
pGM3181 carries TRPl as a selectable marker and the test gene HIS3 
with an /&RI linker at nt -80. whtle all sequences upstream of this 
site, Including the UAS, are deleted. 
2.2. DNA hindirlg ussy,, immunoussuy nd protease chppwg 
Bindmg reactions, usmg 5510 pg of total protem extract were car- 
ried out as described [S] with the followmg modifications: total volume 
of the bmdmg reaction was 20 ~1. l-5 x 10’ cpm of probe and I fig 
of poly(dI-dC) was added to the reaction as non-specific competitor: 
binding reacttons were carrted out for 10 min at 20°C loaded directly 
on 5% polyacrtlamide gels and run m 0.5 x TBE at 200 V, 25 mA. 
Competition experiments were carried out by adding unlabelled com- 
petitor to the reactton 5 mm before adding the probe. 
For immunoassay. 5pg of crude extracts were incubated for 30 mm 
on ice with varying amounts of either polyclonal antibody raised 
agamst RAP1 (a gift from S Gasser) or of preimmune serum, in 
bmding buffer and poly(dI-dC). as described above. Probe was then 
added and the bmdmg assay was carried out as usual. 
Limited proteolysis of complexes was performed by incubatmg sam- 
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pies after the binding reaction for 10 min at room temperature m the 
presence of different amounts of proteinase K (IO pg/,@ 0.1 ng/pl; 1 
ng/@l). Samples were then directly electrophoresed on 5% poly- 
acrylamide gels in 0.5 x TBE. 
protein which was then purified by preparative SDS-PAGE according 
to Hager et al. [I l] except that 8 M urea was used as denaturing agent. 
2.6. RNA preparation und Northern blottmg 
2.3. Preparation of protein extracts 
Crude yeast extracts were prepared as described [9]. 
Cells were grown m supplemented minimal medium lacking trypto- 
phan. Isogenic rap” and RAP wt strains were grown at 26°C from 
spores dissected from the same ascus. Aliquots of the cultures were 
incubated for 4 h at 37°C or at 36°C and RNA was extracted as 
described [3]. 
2.4. Preparation of probes, foorprintmg assoys 
The Polyoma enhancer B-domain fragment was cloned by BunzHI 
linkers into vector pGEM 4; the plasmid was first cut at the XbaI site, 
labelled on the coding strand with [c? P]dCTP with Klenow enzyme 
and recut with SmaI. The labelled B-domain fragment was purified on 
a 5% polyacrylammide gel and used for footprmtmg. Bmding reac- 
tions containing 1-3 x lo5 cpm of probe and either 20&3Opg of protein 
extract or 100 ng of purified RAP1 were carried out for 10 min at 
20°C. MgCl, 10 mM final and DNase I (IO-20 ng/pl final) were added 
to the mixture and digestion was carried out for 1 min at 25°C; the 
reaction was stopped by the addition of 25 mM final EDTA and 
samples were immediately loaded on a non-denaturing poly- 
acrylamide gel; the complexed and free probes were cut out from the 
gel, electroeluted, phenol extracted and run on a 6% polyacrylamide, 
8 M urea sequencmg gel. A Maxam and Gdbert A+G reaction was 
carried out on the same probe to localize positlon of the footprmt. 
3. RESULTS 
3.1. Yeust proteins that bind to the Po[vonla e&amer 
The Polyoma enhancer (as other viral enhancers) is 
a functionally and structurally composite control ele- 
ment; it is contained within a segment of 246 bp (nt 
5022-5267) essential for viral transcription and replica- 
tion in differentiated mouse cells (Fig. 1A) [3]. 
2.5. Pu@icat~on of RAP1 produced m E. coli 
E coli strain BL 21 [lo] was used to induce expression of RAP1 
A ) The Polyoma enhancer 
Chromatography of total yeast extracts on heparin- 
Sepharose fractionates two classes of proteins that bind 
specifically to the enhancer in gel-retardation assays: 
one, eluting at a concentration of 0.3 M KCl, binds to 
the B-domain and one that elutes at 0.6 M KC1 and 
binds to the A-domain (data not shown) (see scheme in 
Fig. 1A). The protein that binds to the latter domain 
A-domain 
Bell Pvull 
B-Domain 
Stul Pvull 
mouse proteins 
(5022) (5130) 
(5224) (5267) 
1 
I I 
NFD AP3 APl AP2 EF-C PEB, AP3 
- +- DE-8 
PEB3 FWWGMENT 
yeast proteins 
Y API RAP1 
B) The B-Domain sequence 
i----s DE-S FRAGMENT--_---j 
Fig. 1. (A) The Polyoma enhancer [31]. Two major functional domains have been identified within the Polyoma enhancer: the A-domam (109 bp) 
located between the Bcfl (nt 5022) and PvuII (nt 5130) restriction sites, and the B-domain (137 bp) located between the PwII (nt 5130) and the 
PvuII (nt 5267) restrlction sites [2]. Shown m the figure are approximate locations of binding sites for mouse [31] and yeast (this paper) nuclear 
proteins. (B) B-Domain sequence. The DE-S fragment is indicated (between StuI and PvuII restriction sites). Boxed regions indicate the two RAP1 
consensus sequences. Also indicated is the RAP1 footprint (yeast) and the so-called Peb III footprint (mammals: see sectlon 4). The DE-S fragment 
IS the minimal region necessary for protein bindmg to the B-domain m yeast. 
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Fig. 2. DNase I protection on the B-domain. DNAse I protection conferred by incubation of end-labelled B-domain fragment with either total 
yeast extract (left panel) or purified RAP1 protein (right panel) (for detads see section 2.4). Lanes ‘- ’ indicate non-complexed probe; lanes ‘+’ 
indicate complexed probe: lane ‘seq’ contains an A+G Maxam and Gilbert reaction Duplicate lanes contam 100 fig/ml and 200 &ml of 
DNase I 
appears, by its sequence specificity, to be a member of 
the yAP1 family (unpublished results): members of this 
family have been shown to bind to the SV40 enhancer 
[12,13]. 
We looked more carefully at the B-domain, and iden- 
tified the region responsible for protein binding by dele- 
tion mapping of this domain (nt 5224 and 5267, the 
DE-S fragment; Fig. 1A and B) (data not shown). 
DNase I footprinting of the B-domain was carried 
out on the 137 bp PvuII fragment located between nt 
5130-5267. 24 bp are protected and contain the se- 
quence CCACCCAATCATT (Fig. lB, boxed region 
and Fig. 2. left panel); this sequence diverges by only 
two nucleotides from the consensus binding site for 
yeast factor RAP1 [14]. 
Another adjacent potential RAPl-binding site is de- 
stroyed by the StzJ cut used to create the DE-S frag- 
ment in the deletion mapping experiments (Fig. 1B). 
Actually, an oligonucleotide containing this site in isola- 
tion binds RAP1 very poorly in vitro (data not shown) 
indicating that the sequence context of the RAP1 con- 
sensus is also important. 
The same DNase I footprint of the B-domain was 
observed when this DNA segment was reacted with 
purified RAP1 (prepared after expression of the cloned 
gene in E. co/i;) (Fig. 2, right panel). 
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3.2. Identification of the yeast proteh that binds to the 
B-domain 
We verified the hypothesis that the yeast protein 
bound to the B-domain was RAP1 by immunoassay. 
Pre-incubating S. cerevisiae extracts with polyclonal an- 
tibodies raised against RAP1 before the binding reac- 
tion alters the mobility of the complex on DE-S frag- 
ment. Pre-incubation with preimmune serum has no 
effect (Fig. 3). This is further and compelling evidence 
that, under our experimental conditions, RAP1 is in- 
volved in the formation of the protein-DNA complex 
on the B-domain. 
3.3. On/J’ RAPI birlds to the Polyoma ehncer B-do- 
main 
In yeast promoters, RAP1 is found to activate tran- 
scription in conjunction with other UAS elements 
[6,15,16]. We could not detect other abundant proteins 
binding to the B-domain in vitro, although less abun- 
dant transcriptional activators might go undetected in 
the mobility shift assay. RAP1 has been shown in some 
cases to exert its effects by interaction with other pro- 
teins. In some contexts its transcriptional activity is me- 
diated by GAL1 1 [17] while transcriptional repression, 
upon binding to silencers, and telomere length (and 
chromosome maintenance), upon binding to telomeres, 
is affected in association with yet another protein (RlF) 
1181. 
We have tested for the presence of other proteins 
bound to the B-domain fragment by comparing the 
products of limited proteolytic cleavage of DNA-pro- 
tein complexes formed with crude extract and with puri- 
fied RAPl. The patterns of partial degradation are iden- 
t 
ANTISERUM PRE IMMUNE 
SERUM 
Fig. 3. Effect of antiserum against RAP1 on complex formation after 
incubation of 5 /g of total yeast extract with labelled DE-S fragment 
from the Polyoma enhancer. 
/III/II I 
PROTEINASE K 0 - - 0 s - s 
protein crude purlfled RAP1 
Fig. 4. Effects of limited proteolysls on electrophoretic mobility shifts 
of protem/B-domam complexes: comparison of proteinase K clipping 
patterns obtamed after incubation of either 5 fig of crude yeast extract 
or 100 ng of purlfied RAP I protem to the B-domam fragment. Lanes 
‘/’ mduzate no protemase K m the reaction 
tical, suggesting that the only protein in the extracts 
binding to the enhancer is RAP1 (Fig. 4). 
3.4. Activity, in viva 
We have tested for B-domain transcriptional activity 
using a plasmid-borne HIS3 test gene (pGM3 181) 
served by a promoter in which natural UAS elements 
at nt -70 had been truncated and replaced with the 
enhancer elements [3]. We tested histidine prototrophy 
and measured HIS3 RNA levels by Northern analysis. 
A single copy of the B-domain was quite active by both 
criteria in either plasmid-borne or chromosomally inte- 
grated constructs (section 2.1) (data not shown). 
The 78 bp DE-S fragment (40 bp enhancer + 38 bp 
linker) was as active as the entire B-enhancer in inte- 
grated constructs (data not shown). and transcriptional 
activation of HIS3 test gene was strongly curtailed in a 
RAPl” mutant after 2 h at the non-permissive tempera- 
ture (Fig. 5). 
These findings demonstrate that RAP1 binds to a 
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Fig. 5. Northern blot analysis showing dependence on RAP1 of tran- 
scriptional activation by the DES fragment in plasmid pGM3 18 1 after 
chromosomal integration at the TRYPI locus. (Top panel) Scheme of 
test gene used (for details see section 2.1 and [3]). (Bottom panel) Total 
RNA was prepared from yeast mutant rapl’” and the RAP wt isogenic 
strain, run on 1% agarose, 6% formaldehyde gels and transferred to 
mtrocellulose. Probe for HIS3 was a uniformly ‘*P-labelled single- 
stranded RNA probe. Quantity of RNA was normalized by hybridiza- 
tion to a labelled DNA probe homologous to the chromosomal LEU2 
gene. Lanes ‘I’ indicate transcription of the HIS3 test gene in the 
absence of enhancer sequences. Lanes ‘DES’ indicate transcription of 
HIS3 test gene driven by the DE-S fragment. 
sequence in the Polyoma enhancer in vivo and is respon- 
sible for transcriptional activation in yeast cells. 
4. DISCUSSION 
There are now several examples of transcriptional 
regulatory elements from higher eukaryotes, including 
the Polyoma enhancer, that stimulate expression in 
transcriptional fusions in yeast. when substituted for 
native UAS elements [3,4,12]. Yeast proteins have been 
found to bind, in such chimaeric promoters, to the same 
motifs that are responsible for transcriptional activation 
in higher eukaryotes [12,19,20]. 
We show here that, under certain conditions, tran- 
scriptional activity of the Polyoma enhancer B-domain 
in yeast depends uniquely on the yeast multifunctional 
protein RAPl. This result was somewhat unexpected 
because, in yeast promoters, RAP1 is usually associated 
with other transcriptional activators such as GCN4 and 
ABFl [15,21]. Furthermore, in a different promoter, we 
found that the B element is inactive, in single copy, in 
yeast, although it did significantly reinforce transcrip- 
tion when in multiple copies or in conjunction with the 
A-domain enhancer [3]. The effect of promoter context 
on the relative importance of the two domains of the 
Polyoma enhancer had been previously observed in 
mouse cells [2,22]. 
There has been little work on protein binding to the 
B element perhaps because, in most contexts, the entire 
B-domain is dispensable and has been considered of 
secondary functional importance. Careful studies of this 
region mostly concern the effect of mutations that ex- 
tend the host-range of Polyoma to undifferentiated cells 
[23,24]. Also, this same domain is a strong transcrip- 
tional activator in mouse fibroblasts when artificially 
linked to the SV40 promoter and this activation is abol- 
ished upon removal of the 40 bp DE-S sequence (the 
St&PvuII fragment) [22]. 
So far, we have failed to detect mammalian proteins 
that footprint on the DE-S fragment RAP1 sequence, 
perhaps because HeLa nuclear extracts, which we have 
used as a source of mammalian DNA binding proteins, 
contain a predominant protein species whose footprint 
partially overlaps the RAP1 sequence (Pollice and 
Gilson, unpublished results) (Fig. 1B). Others have ob- 
served an identical footprint (Kryzke and Yaniv, per- 
sonal communication). 
EBP20. a rat liver nuclear protein that binds with 
high avidity to a primary site in the enhancer core re- 
gion, also binds with lower avidity to the DES fragment 
and presents a DNasel footprint that encompasses the 
RAP1 site [25]. It is also intriguing, that the Polyoma 
RAP1 site contains a pentanucleotide (CCAAT) which 
matches the consensus for binding of proteins of the 
NFl/CTF family that are implicated in replication as 
well as transcription. Interestingly, the 30 amino acid N- 
terminus of a member of this family presents a 30% 
identity with the C-terminus of RAP1 [26]. 
Although no mammalian homologue of RAP1 has 
been described in mammals or for that matter in any 
other organisms, the presence of RAPl-binding motifs 
J- 4 
affinity 
XJ&@J’: a t .~$,a t t t TEF - 2 +++ 
r:~~z.k;$ixx polyoma 1 + 
q@$~zk.~zg.~rT~ polyoma 2 ++ 
.:.~$CT;.L;CLTI~.~.C SV40 + 
.;c&$.:.~: T ~,j/+X(: B PV nt 
Fig, 6. Potential RAP1 bmding sites in other viral enhancers. Symbols 
‘f’ indicate relative binding affinity, ‘nt’. not tested. The SV40 se- 
quence is in the ‘late’ orientation.TEF-2 is from the UAS of the TEF? 
gene. containing a high affinity RAP1 site. 
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in the SV40 and BPV enhancers (Fig. 6), suggests that 
there may indeed be such a protein. In fact we observed 
that purified RAP1 binds to the SV40 enhancer (data 
not shown). 
The discovery of such a homologue would be poten- 
tially of great interest because of the central role this 
protein plays in yeast cells both in gene expression and 
in chromosome dynamics. RAP1 is a scaffold-bound 
[27] protein necessary for transcriptional activation of 
many house-keeping genes in yeast [2&30] as well as for 
silencing of the mating type genes and for telomeres 
stability. 
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